Suely Roman Lopez
Cardiovascular Disease · Arecibo, PRNPI 1851883581
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,297 of the $8,494 with a category attached, or 62.4%. 19 manufacturers reported payments, led by Abbott at 48.6% of the total. 2025 is the largest year on record at $4,285, more than ten times the $329 reported in 2021.
Across 107 payments — averaging $79.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- AstraZeneca$701
- Shockwave Medical, Inc$633
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$583
- Cvrx, Inc.$491
- Boston Scientific$317
- plus $2K from 13 others
What the payments were for
- Travel & lodging$2,97035%
- Food & beverage$5,29762%
- Education$2273%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 46 | $4,128 |
| AstraZeneca | 6 | $701 |
| Shockwave Medical, Inc | 6 | $633 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $583 |
| Cvrx, Inc. | 3 | $491 |
| Boston Scientific | 6 | $317 |
| Abiomed | 5 | $289 |
| Impulse Dynamics (USA) Inc. | 2 | $270 |
| Astellas Pharma US Inc | 3 | $255 |
| Novartis | 9 | $171 |
| Inari Medical, Inc. | 1 | $167 |
| Actelion Pharmaceuticals US, Inc. | 1 | $142 |
| E.r. Squibb & Sons, L.L.C. | 1 | $130 |
| Bridgebio Pharma, Inc. | 1 | $105 |
| Medtronic | 1 | $28 |
| PBG Puerto Rico LLC | 1 | $26 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Cardiva Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- 2ND GEN CENTRIMAG PRIMARY CONSOLE$1,838
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$1,552
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$555
- OPTIMIZER$541
- Barostim Neo System$491
- FARXIGA$344
- Impella$249
- BRILINTA$236
- FLOWTRIEVER CATHETER, S$167
- CT THROMBECTOMY SYSTEM KIT$167
- JETi Peripheral Catheter$142
- UPTRAVI$142
- OPSUMIT$142
- CAMZYOS$130
- LOKELMA$120
- Attruby$105
How this compares
$8,494 in reported general payments places this provider in the 80th percentile of 267 cardiovascular disease providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 11 | $18,370 |
| EliquisApixaban | 11 | $9,826 |
| Bumetanide | 13 | $507 |
| Valsartan | 17 | $370 |
| Metoprolol Succinate | 21 | $259 |
| ClopidogrelClopidogrel Bisulfate | 23 | $189 |
| Atorvastatin Calcium | 29 | $155 |
| Spironolactone | 16 | $65 |
| Amlodipine Besylate | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $701 | $18,37011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 267 cardiovascular disease providers in Puerto Rico.
Other cardiovascular disease in Arecibo
- Juan Nieves-RiveraArecibo$50K
- Jorge Ballester MaldonadoArecibo$12K
- Victor Salgado BravoArecibo$9K
- Karen Rodriguez MaldonadoMayaguez$231K
- Jose NovoaBayamon$209K
- Manuel GuzmanSan Juan$203K
- Luis Rosado CarrilloGuaynabo$173K
- Jorge GonzalezCaguas$114K
- Luis GelyCaguas$89K
- Luis Renta RosaCarolina$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.